514 Episodes

  1. S7 Ep39: Community Perspectives on Integrating and Interpreting Molecular Testing Results in NSCLC

    Published: 10/17/2022

  2. S7 Ep38: FDA Approval Insights: Selpercatinib in RET Fusion–Positive Solid Tumors

    Published: 10/13/2022

  3. S7 Ep37: Brentjens on the Next Chapter of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

    Published: 10/10/2022

  4. S7 Ep36: Velcheti Discusses Mobile Telehealth-Based Research to Close Cancer Care Gaps

    Published: 10/6/2022

  5. S7 Ep35: FDA Approval Insights: Durvalumab Plus Gemcitabine and Cisplatin in Biliary Tract Cancer

    Published: 10/3/2022

  6. S7 Ep34: Shepard Discusses Symptoms, Management, and Future Directions in Desmoid Tumors

    Published: 9/29/2022

  7. S7 Ep33: Deol on the Importance of a Well-Rounded Fellowship Experience

    Published: 9/26/2022

  8. S7 Ep32: Patel Provides Insight Into Post-Transplant Complications in Myeloid Disorders

    Published: 9/22/2022

  9. S7 Ep31: FDA Approval Insights: Pemigatinib in FGFR1-Rearranged Myeloid/Lymphoid Neoplasms

    Published: 9/19/2022

  10. S7 Ep30: Leal Sheds Light on Symptoms and Treatment of Lambert-Eaton Myasthenic Syndrome

    Published: 9/15/2022

  11. S7 Ep29: Elamin Elaborates on Poziotinib in EGFR Exon 20–Mutant NSCLC

    Published: 9/12/2022

  12. S7 Ep28: Chen Discusses Diagnosis, Management, and Disparities in Cutaneous T-cell Lymphoma

    Published: 9/8/2022

  13. S7 Ep27: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Low Unresectable or Metastatic Breast Cancer

    Published: 9/5/2022

  14. S7 Ep27: Iams and Shah Break Down Lambert-Eaton Myasthenic Syndrome in SCLC and Other Neuroendocrine Cancers

    Published: 9/1/2022

  15. S7 Ep26: Bekaii-Saab, George, and von Mehren Discuss Pivotal Findings in GIST, TGCT, and RAS/RAF–Mutated Solid Tumors

    Published: 8/29/2022

  16. S7 Ep25: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Mutant NSCLC

    Published: 8/25/2022

  17. S7 Ep24: Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer

    Published: 8/22/2022

  18. S7 Ep24: Goldberg and Sussman Dissect Disparities in Gastric Cancer Mortality Rates

    Published: 8/18/2022

  19. S7 Ep23: FDA Approval Insights: Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer

    Published: 8/15/2022

  20. S7 Ep22: Katz Considers the Role of Neoadjuvant Chemoradiation in Borderline Resectable Pancreatic Cancer

    Published: 8/11/2022

20 / 26